Press Releases - WDM Group PR Network  

Putting Cancer News in Context for Patients

AUSTIN, Texas, Sept. 28, 2012 /PRNewswire/ -- 1-800-Oncologist, Inc. announced today the launch of its Contributing Expert program for oncology and radiology specialists.  Members of 1-800-Oncologist's national Contributing Expert network are key opinion leaders in the cancer field that help...

MIGS and Goniotomy Procedures Improved With Volk Surgical Gonio Lens

MUMBAI, September 28, 2012 /PRNewswire/ -- Sterilisable Lens Provides High Resolution Views of Trabecular Meshwork For Micro-Invasive Glaucoma Surgery (MIGS) and goniotomy procedures, Volk's new Surgical Gonio Lens provides clear anterior chamber angle images. Photo: http://halmapr.com/volk/SurgiGonioRelease.jpg With a 1.2x image...

TPI Reports Fiscal Year 2012 Financial Results

CHENGDU, China, Sept. 28, 2012 /PRNewswire/ -- Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the...

Successful Integration Leads to New Look, Name For Merged Human Service Organizations

CLEVELAND, Sept. 28, 2012 /PRNewswire/ -- Center for Families and Children, West Side Ecumenical Ministry and El Barrio, which came together last year to form one new organization, unveiled a unified brand today. The new name is The Centers for Families...

3 Second Health™ Natural Liquid Multi-Vitamin Shot to Make Worldwide Debut at 2012 Mr. Olympia Fitness Expo in Las Vegas, Nevada

LAS VEGAS, Sept. 28, 2012 /PRNewswire/ -- 3 Second Health all natural liquid multi-vitamin shot will be officially on sale at the 2012 Mr. Olympia Fitness Expo September 28th and 29th at the Las Vegas Convention Center. This product is the...

Ablynx Proposes to Strengthen Its Board With the Appointment of Dr Roger Perlmutter and Dr Russell Greig

For more information, please contact Ablynx: Dr Edwin Moses Chairman and CEO t: +32 (0)9 262 00 07 m: +44 (0)7771 954 193 / +32 (0)473 39 50 68 e: Email Contact Marieke Vermeersch Associate Director Investor Relations t: +32 (0)9 262 00 82 m: +32 (0)479 49 06 03 e: Email Contact Follow us on Twitter @AblynxABLX M:Communications: Mary-Jane Elliott, Amber Bielecka, Claire Dickinson t: +44 207 920 2330 e: Email Contact

Vital Therapies, Inc. Announces First Closing of $76 Million Staged Financing to Fund Phase 3 Pivotal Clinical Trials of ELAD(R) in USA and EU

CONTACT:
Terry Winters
Chairman & CEO
Duane Nash
CBO
Vital Therapies, Inc.
858-673-6840

Horizon Pharma to Present at the 11th Annual BIO Investor Forum

Contacts
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Email Contact

Media
Geoff Curtis
DJE Science
312-233-1253
Email Contact

Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006
Email Contact

Peregrine Pharmaceuticals Announces New Location of Annual Meeting of Stockholders

Contact:
Christopher Keenan or Jay Carlson
Peregrine Pharmaceuticals, Inc.
(800) 987-8256
info@peregrineinc.com

Calyx's Operating Subsidiary Reports Successful Commercial Production of Resonance Brand Feedstock Crop across Western Canada

Calyx Bio-Ventures Inc.
W. Hugh Notman
President & CEO
604-689-2495
hnotman@calyxbio.com
or
Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations
778-998-9242
kreynolds@calyxbio.com
| ... 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 | 128 | 129 | 130 | 131 | 132 | 133 | 134 | 135 | 136 | 137 | 138 | 139 | 140 | 141 | 142 | 143 | 144 | 145 | 146 | 147 | 148 | 149 | 150 | 151 | 152 | 153 | 154 | 155 | ...


Featured Articles + MORE Featured Articles >>